Org 30029: A New Cardiotonic Agent Possessing Both Phosphodiesterase Inhibitory and Calcium‐Sensitising Properties
- 1 September 1990
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 8 (3) , 179-202
- https://doi.org/10.1111/j.1527-3466.1990.tb00392.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Screening of positive inotropic agents in isolated cardiac preparations from different sourcesJournal of Pharmacological Methods, 1989
- The myocardium in congestive heart failureThe American Journal of Cardiology, 1989
- Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flowThe American Journal of Cardiology, 1989
- New mechanisms for positive inotropic agents: Focus on the discovery and development of imazodanCardiovascular Drugs and Therapy, 1989
- An explanation for varying views about digitalis efficacy in congestive heart failureCardiovascular Drugs and Therapy, 1989
- Digoxin revived?Cardiovascular Drugs and Therapy, 1989
- Heart failure and airway obstructionInternational Journal of Cardiology, 1987
- Pharmacology of enoximoneThe American Journal of Cardiology, 1987
- Influence of association and of positive inotropic drugs on calcium binding to cardiac troponin CBiochemical and Biophysical Research Communications, 1987
- Newer Positive Inotropic Agents in the Treatment of Chronic Cardiac FailureDrugs, 1987